Literature DB >> 16311774

Validation of laser Doppler fluxmetry as a method of assessing neo-angiogenesis in laryngeal tumours.

A Jacob1, B E Varghese, M B Birchall.   

Abstract

Our intention was to validate the hypothesis that laser Doppler fluxmetry would give a valid representation of underlying tissue blood flow and would provide a reliable tool for measuring blood flow in human laryngeal cancers. This was an experimental prospective study. We performed laser Doppler fluxmetry on 20 patients with laryngeal cancer and compared the values obtained through this method with manual counting of microvessel density from biopsies, the accepted gold standard. We demonstrated good inter- and intraobserver variability in our estimation of microvessel density. We then compared microvessel density with laser Doppler fluxmetry, and using Spearman's test to assess nonparametric correlation, we obtained a correlation coefficient of 0.4 (P value: 0.15). To our knowledge, this study is the first of its kind to demonstrate a positive trend between angiogenesis measured conventionally when compared with laser Doppler fluxmetry.

Entities:  

Mesh:

Year:  2005        PMID: 16311774     DOI: 10.1007/s00405-005-1020-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  12 in total

1.  Quantitative evaluation of angiogenesis in laryngeal cancer by digital image measurement of the vessel density.

Authors:  Tomasz Krecicki; Danuta Dus; Joanna Kozlak; Wojciech Tarnawski; Michal Jelen; Maria Zalesska-Krecicka; Teresa Szkudlarek
Journal:  Auris Nasus Larynx       Date:  2002-07       Impact factor: 1.863

2.  Laser Doppler flux-metry as an experimental tool in laryngology.

Authors:  A Jacob; M A Birchall
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-02-11       Impact factor: 2.503

Review 3.  Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation.

Authors:  P B Vermeulen; G Gasparini; S B Fox; M Toi; L Martin; P McCulloch; F Pezzella; G Viale; N Weidner; A L Harris; L Y Dirix
Journal:  Eur J Cancer       Date:  1996-12       Impact factor: 9.162

4.  Evaluation of laser-Doppler flowmetry as a measure of tissue blood flow.

Authors:  G J Smits; R J Roman; J H Lombard
Journal:  J Appl Physiol (1985)       Date:  1986-08

5.  Laser Doppler flux-metry in laryngeal squamous cell carcinoma.

Authors:  A Jacob; J P Davis; M A Birchall
Journal:  Clin Otolaryngol Allied Sci       Date:  2003-02

6.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

7.  Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis.

Authors:  S B Fox; R D Leek; M P Weekes; R M Whitehouse; K C Gatter; A L Harris
Journal:  J Pathol       Date:  1995-11       Impact factor: 7.996

8.  Quantification of microvessel density of breast carcinoma: an assessment of the inter- and intraobserver variation.

Authors:  P Ingeholm; L Pedersen; S Holck
Journal:  Breast       Date:  1999-10       Impact factor: 4.380

Review 9.  Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy.

Authors:  A L Harris
Journal:  Recent Results Cancer Res       Date:  1998

10.  Comparison of methods of microvascular staining and quantification in prostate carcinoma: relevance to prognosis.

Authors:  Birgitte Vrou Offersen; Michael Borre; Flemming Brandt Sørensen; Jens Overgaard
Journal:  APMIS       Date:  2002-02       Impact factor: 3.205

View more
  1 in total

Review 1.  Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma.

Authors:  Jacobus F A Jansen; Jason A Koutcher; Amita Shukla-Dave
Journal:  Angiogenesis       Date:  2010-04-11       Impact factor: 9.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.